· 18/11/2020
Phase I/IIa study in subjects with Retinitis Pigmentosa
· 18/11/2020наем
KODIAK: A phase II study in patients with the exudative form of AMD
· 18/11/2020наем
REVERS: Study using postbiotics in AMD patients
· 18/11/2020наем
ISEE2008: Phase III clinical trial in patients with dry AMD
· 14/02/2020
Clinical trial OAKS-DERBY: efficacy and safety of APL-2 in the treatment of geographic atrophy secondary to AMD
· 26/11/2019наем
TALON clinical trial: Efficacy and safety of brolacizumab in the treatment of exudative AMD
· 13/11/2019наем
Research project MICROBEYEOME
· 09/04/2019
LUCERNE clinical trial: efficacy and safety of FARICIMAB regarding aflibercept in the treatment of exudative age-related macular degeneration
· 03/03/2019
RHINE – Phase III study in the treatment of diabetic macular oedema
· 03/10/2018
THR-317-002: Clinical trial for the treatment of Diabetic Macular Oedema
· 03/10/2018
Clinical Trial KESTREL: Efficacy and safety of brolucizumab in comparison with aflibercept in diabetic macular edema
· 10/05/2018
Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease
· 28/07/2017
Geographic atrophy phenotype identification by cluster analysis
· 24/04/2017
Drusen Ooze: A Novel Hypothesis in Geographic Atrophy
· 30/08/2016
A Swine Model of Selective Geographic Atrophy of Outer Retinal Layers Mimicking Atrophic AMD: A Phase I Escalating Dose of Subretinal Sodium Iodate